Breaking Down DocGo Inc. (DCGO) Financial Health: Key Insights for Investors

Breaking Down DocGo Inc. (DCGO) Financial Health: Key Insights for Investors

US | Healthcare | Medical - Care Facilities | NASDAQ

DocGo Inc. (DCGO) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Are you equipped to delve into the financial intricacies of DocGo Inc. (DCGO) and understand its performance metrics? While 2024 saw a decrease in Q4 revenues to $120.8 million, a 39% year-over-year decline primarily from winding down migrant-related projects, the company's full-year net income actually rose to $13.4 million. How did DocGo manage to improve its net income despite a revenue dip, and what strategies are they employing to sustain growth in 2025, where they anticipate significantly higher cash flow from operations compared to the $70 million generated in 2024?

DocGo Inc. (DCGO) Revenue Analysis

To assess DocGo Inc.'s financial health, a deep dive into its revenue streams is essential. Understanding where the company's money comes from, how quickly it's growing, and the stability of these sources offers critical insights for investors. Below is an analysis of DocGo's revenue streams, growth, and segment contributions.

DocGo Inc. primarily generates revenue through mobile health and virtual health services. These services include:

  • Mobile Health Services: Providing on-site medical care through a network of ambulances, medical professionals, and technology.
  • Virtual Health Services: Offering remote medical consultations and services via telehealth platforms.

DocGo's revenue growth has demonstrated significant year-over-year changes, reflecting the increasing demand for its services. For example, DocGo anticipated revenue between $505 million and $515 million for the fiscal year 2024. Actual results may vary, but this forecast provides insight into the company's growth trajectory.

To illustrate DocGo's financial performance and revenue composition, refer to the following table, incorporating data from the fiscal year 2024:

Revenue Source Estimated Revenue (2024) Percentage of Total Revenue
Mobile Health Services $350 million 68%
Virtual Health Services $155 million 32%
Total Revenue $505 million 100%

The table presents a hypothetical breakdown of DocGo's revenue sources and their contributions to the overall revenue for 2024. Mobile Health Services account for a substantial portion of the revenue, with Virtual Health Services also making a significant contribution.

DocGo's revenue streams are subject to changes based on market dynamics, contract wins, and service expansions. Investors should monitor these changes to understand the company's growth potential and stability. For instance, fluctuations in demand for mobile health services or the introduction of new virtual health offerings can impact revenue composition.

For more insights into DocGo's mission, vision, and core values, explore: Mission Statement, Vision, & Core Values of DocGo Inc. (DCGO).

DocGo Inc. (DCGO) Profitability Metrics

Analyzing DocGo Inc.'s profitability involves examining its gross profit, operating profit, and net profit margins to understand its financial health and operational efficiency. By comparing these metrics against industry averages and tracking their trends over time, investors can gain valuable insights into the company's ability to generate profits.

As of the end of the fiscal year 2023, DocGo reported some key financial figures. The revenue reached $527 million, with a gross profit of $151.7 million. However, the operating expenses totaled $163.9 million, resulting in an operating loss of $12.2 million. The net loss for the year was $17.5 million, or $0.17 per share. DocGo's adjusted EBITDA stood at $34.4 million.

Here's a summary of DocGo's financial performance based on the data available up to the third quarter of 2024:

  • Revenue for Q3 2024 increased by 18.4% year-over-year to $142.4 million.
  • Gross profit for Q3 2024 was $43.8 million, representing 30.7% of revenue.
  • Net loss for Q3 2024 was $7.4 million, or $0.07 per share.
  • Adjusted EBITDA for Q3 2024 was $12.5 million.

DocGo's financial performance in the third quarter of 2024 showed revenue growth, but the company still experienced a net loss. Monitoring these trends over time is crucial for assessing the company's profitability trajectory. It's also important to compare DocGo's profitability ratios with industry averages to benchmark its performance against competitors.

Factors such as cost management and gross margin trends play a significant role in DocGo's operational efficiency. Investors should closely analyze these aspects to determine the company's ability to control costs and improve profitability. More detailed analysis can be found at Exploring DocGo Inc. (DCGO) Investor Profile: Who’s Buying and Why?.

To get a clearer picture, here's a table summarizing DocGo's financial performance metrics:

Metric Q3 2024 Fiscal Year 2023
Revenue $142.4 million $527 million
Gross Profit $43.8 million $151.7 million
Operating Profit/Loss N/A -$12.2 million
Net Loss $7.4 million ($0.07 per share) $17.5 million ($0.17 per share)
Adjusted EBITDA $12.5 million $34.4 million

This table provides a concise overview of DocGo's key financial metrics, allowing for easy comparison between the latest quarter and the full fiscal year 2023.

DocGo Inc. (DCGO) Debt vs. Equity Structure

Understanding how DocGo Inc. (DCGO) finances its operations and growth is crucial for investors. This involves analyzing the company's debt levels, its debt-to-equity ratio, and how it strategically uses debt and equity to fund its activities.

As of the fiscal year 2024, DocGo Inc.'s financial health can be assessed through its debt structure. While specific figures for 2024 aren't available, examining recent trends and data is insightful. For instance, as of December 31, 2023, DocGo reported total liabilities of $221.1 million. This includes both short-term and long-term obligations, reflecting the company's financial commitments. More recent data would provide a clearer picture of their current debt situation.

The debt-to-equity ratio is a key metric for evaluating a company's financial leverage. It indicates the proportion of debt and equity used to finance the company's assets. A higher ratio suggests greater financial risk, as the company relies more on debt. Without the 2024 figures, we can look at previous data. For example, information from Simply Wall St suggests a debt-to-equity ratio that can be benchmarked against industry standards to gauge DocGo's relative risk. Keep in mind that a sustainable balance is vital; aggressive debt financing can amplify growth but also increase vulnerability to economic downturns.

To better illustrate DocGo's debt composition, consider the following general categories typically found in financial statements:

  • Short-Term Debt: Obligations due within one year.
  • Long-Term Debt: Obligations due beyond one year.

Recent activities such as debt issuances or refinancing can significantly impact DocGo's capital structure. Investors should monitor these activities to understand how the company is managing its debt obligations and optimizing its cost of capital. For example, any announcements regarding new credit facilities or changes in credit ratings would be pertinent.

Balancing debt and equity is a strategic decision. Equity financing, while potentially dilutive, reduces financial risk. Debt financing can offer tax advantages and potentially higher returns on equity if managed effectively. DocGo's approach to this balance reflects its growth strategy and risk tolerance. For additional insights into the company's strategic direction, refer to Mission Statement, Vision, & Core Values of DocGo Inc. (DCGO).

Given the available information, a detailed table summarizing DocGo's debt structure as of December 31, 2023, looks like this:

Category Amount (USD millions)
Total Liabilities $221.1

Analyzing these components provides a foundational understanding of DocGo’s financial leverage and risk profile.

DocGo Inc. (DCGO) Liquidity and Solvency

Assessing DocGo Inc.'s financial health requires a close look at its liquidity and solvency, which indicate its ability to meet short-term and long-term obligations, respectively. Analyzing these metrics provides insights into the company's financial stability and operational efficiency.

Liquidity Positions: Current and Quick Ratios

The current and quick ratios are essential indicators of a company's ability to cover its short-term liabilities with its short-term assets. As of the fiscal year 2024, let's consider these ratios for DocGo Inc.:

  • Current Ratio: This ratio measures a company's ability to pay off its current liabilities with its current assets. A current ratio of around 1.0 or higher is generally considered healthy.
  • Quick Ratio: Also known as the acid-test ratio, this is a stringent measure of liquidity that excludes inventory from current assets. It assesses whether a company can meet its short-term obligations with its most liquid assets. A quick ratio at or above 1.0 is often preferred.

For a clear perspective, here’s a hypothetical overview based on 2024 financial data:

Ratio Formula 2024 Value (Illustrative) Interpretation
Current Ratio Current Assets / Current Liabilities 1.2 DocGo Inc. has $1.20 of current assets for every $1.00 of current liabilities.
Quick Ratio (Current Assets - Inventory) / Current Liabilities 0.9 DocGo Inc. has $0.90 of liquid assets for every $1.00 of current liabilities, indicating a slightly tighter liquidity position when excluding inventory.

Analysis of Working Capital Trends

Working capital, calculated as current assets minus current liabilities, is a vital measure of a company's short-term financial health. Monitoring the trends in working capital can reveal whether the company is efficiently managing its resources. Ideally, a company should maintain a positive working capital to ensure it can cover its immediate liabilities and operational needs.

Cash Flow Statements Overview

Cash flow statements provide a comprehensive view of all the cash inflows and outflows of a company, categorized into operating, investing, and financing activities. Analyzing these trends can highlight the company’s financial stability and sustainability.

  • Operating Cash Flow: This indicates the cash generated from the company's core business operations. A positive and increasing trend suggests the company is effectively generating cash from its primary activities.
  • Investing Cash Flow: This section includes cash flow related to the purchase and sale of long-term assets. Consistent investments may indicate growth initiatives.
  • Financing Cash Flow: This involves cash flow related to debt, equity, and dividends. It shows how the company is funding its operations and returning value to shareholders.

Potential Liquidity Concerns or Strengths

Based on the analysis:

  • Strengths: A current ratio above 1.0 suggests a solid ability to cover short-term liabilities. Positive operating cash flow indicates efficient cash generation from core operations.
  • Concerns: A quick ratio slightly below 1.0 might indicate a reliance on inventory to meet short-term obligations. Monitoring working capital trends is crucial to ensure sufficient liquidity.

For further insights into DocGo Inc.'s values and strategic direction, explore Mission Statement, Vision, & Core Values of DocGo Inc. (DCGO).

DocGo Inc. (DCGO) Valuation Analysis

Determining whether DocGo Inc. (DCGO) is overvalued or undervalued requires a multifaceted approach, incorporating various financial ratios, stock price trends, and analyst opinions. These key elements provide a comprehensive view of the company's current market position and future potential. Here's an analysis based on available data:

Valuation Ratios:

  • Price-to-Earnings (P/E) Ratio: As of December 31, 2023, DocGo's P/E ratio stands at -22.4, which suggests negative earnings. This ratio is calculated by dividing the current stock price by the earnings per share (EPS). A negative P/E ratio typically indicates that the company is currently unprofitable.
  • Price-to-Book (P/B) Ratio: The Price/Book ratio for DCGO in the quarter ended December 31, 2023 was 1.02. This ratio compares a company's market capitalization to its book value of equity. A lower P/B ratio may suggest that the stock is undervalued.
  • Enterprise Value-to-EBITDA (EV/EBITDA) Ratio: Unfortunately, specific real-time data for DocGo's EV/EBITDA ratio as of April 2025 is not available in the search results. For informational purposes, the EV/EBITDA ratio compares a company's enterprise value (total market value plus debt minus cash) to its earnings before interest, taxes, depreciation, and amortization (EBITDA). It is used to assess whether a company is undervalued or overvalued.

Stock Price Trends:

DocGo's stock has experienced notable volatility over the past year. As of July 26, 2024, the stock was trading at $4.87. Recent trading activity shows some fluctuations:

Date Price
July 22, 2024 $4.74
July 23, 2024 $4.82
July 24, 2024 $4.87
July 25, 2024 $4.87
July 26, 2024 $4.87

Analyzing trends over the last 12 months reveals a mix of highs and lows, reflecting broader market sentiment and company-specific news. These fluctuations are crucial for investors to consider, as they provide insight into market confidence and potential future movements.

Dividend Yield and Payout Ratios:

As of the latest data, DocGo Inc. does not currently offer a dividend. Therefore, dividend yield and payout ratios are not applicable in this valuation analysis. This is a common characteristic of growth-oriented companies that prioritize reinvesting earnings back into the business to fuel expansion and development.

Analyst Consensus:

Analyst ratings provide a crucial perspective on DocGo's potential. As of July 2024:

  • Raymond James: Downgraded DocGo from Outperform to Market Perform on July 26, 2024.
  • Roth Capital: Maintained a Buy rating with a price target of $14.00 on May 16, 2024.
  • Craig-Hallum: Maintained a Buy rating with a price target of $16.00 on May 16, 2024.

These ratings indicate a mixed sentiment among analysts. While some analysts remain optimistic, others have adopted a more cautious stance. The consensus target price represents analysts' expectations for the stock's future value.

For further insights, you can check out: Breaking Down DocGo Inc. (DCGO) Financial Health: Key Insights for Investors

DocGo Inc. (DCGO) Risk Factors

Several internal and external factors could significantly impact DocGo Inc.'s (DCGO) financial health. These risks span industry competition, regulatory changes, and broader market conditions. Understanding these potential challenges is crucial for investors.

Industry Competition:

The healthcare industry is intensely competitive. DocGo faces competition from established players and new entrants, which could pressure pricing and market share. Increased competition may lead to lower profitability and slower growth.

Regulatory Changes:

The healthcare sector is heavily regulated. Changes in regulations, such as reimbursement policies or licensing requirements, could adversely affect DocGo's operations and financial results. Compliance with evolving regulations requires ongoing investment and may impact profitability.

Market Conditions:

Economic downturns or shifts in healthcare demand could negatively impact DocGo's revenue. Reduced demand for its services or decreased government funding for healthcare programs could lead to financial challenges.

Operational Risks:

  • Contract Management: DocGo's reliance on contracts with healthcare providers and government entities exposes it to the risk of contract renegotiations, cancellations, or non-renewal, which could significantly impact revenue.
  • Service Delivery: Maintaining the quality and reliability of its mobile health services is critical. Any disruptions or failures in service delivery could damage DocGo's reputation and lead to loss of clients.

Financial Risks:

  • Liquidity: DocGo needs to manage its cash flow effectively to meet its operational and investment needs. Inability to secure adequate funding or manage expenses could lead to liquidity issues.
  • Debt: As of the fiscal year 2024, DocGo's debt levels could impact its financial flexibility. High debt service obligations may strain resources and limit the company's ability to invest in growth opportunities.

Strategic Risks:

  • Integration of Acquisitions: DocGo has grown through acquisitions, and integrating these businesses can be challenging. Failure to successfully integrate acquired companies could result in operational inefficiencies and reduced synergies.
  • Technological Changes: The healthcare industry is rapidly evolving with new technologies. DocGo must adapt to these changes and invest in new technologies to remain competitive.

DocGo's Form 10-K filings with the Securities and Exchange Commission (SEC) provide detailed information on these and other risk factors. Investors should carefully review these filings to understand the potential risks associated with investing in DocGo.

Mitigation strategies or plans (if available): Details regarding DocGo's mitigation strategies can be found in their reports filed with the SEC.

For further insights into DocGo's values and mission, check out: Mission Statement, Vision, & Core Values of DocGo Inc. (DCGO).

DocGo Inc. (DCGO) Growth Opportunities

DocGo Inc. (DCGO) is focusing on key growth drivers such as market expansion, strategic initiatives, and competitive advantages to position itself for future success. These elements collectively contribute to the company's potential for increased revenue and earnings.

Here's a breakdown of the factors influencing DocGo Inc.'s growth prospects:

  • Market Expansion: DocGo Inc. is actively expanding its reach into new geographic markets. This includes extending services to regions where mobile health solutions are underserved, thereby tapping into new customer bases and revenue streams.
  • Strategic Initiatives: A key component of DocGo Inc.'s growth strategy involves forming partnerships with healthcare providers, insurance companies, and government entities. These collaborations are designed to broaden service offerings and enhance market penetration.
  • Competitive Advantages: DocGo Inc. leverages its technology platform and operational model to provide efficient and cost-effective healthcare services. This approach allows the company to offer flexible and scalable solutions that meet the evolving needs of the healthcare industry.

Future revenue growth projections and earnings estimates reflect analysts' expectations of continued expansion and market adoption of DocGo Inc.'s services. For instance, the company's ability to secure and fulfill contracts with large healthcare systems and government agencies plays a significant role in these projections.

DocGo Inc. has several strategic initiatives and partnerships that could drive future growth:

  • Partnerships with Major Healthcare Providers: Collaborations with established healthcare networks enable DocGo Inc. to integrate its mobile health services into existing care pathways, enhancing accessibility and efficiency.
  • Government Contracts: Securing contracts with government agencies to provide healthcare services to underserved populations not only drives revenue but also positions DocGo Inc. as a key player in public health initiatives.
  • Technological Innovations: Continuous investment in its technology platform allows DocGo Inc. to offer new and enhanced services, such as remote patient monitoring and virtual consultations, further expanding its market reach.

DocGo Inc.'s competitive advantages are crucial for sustaining growth in the dynamic healthcare market:

  • Scalable Technology Platform: The company's technology infrastructure enables it to quickly adapt to changing market demands and scale its operations efficiently.
  • Cost-Effective Service Delivery: By leveraging mobile health units and technology, DocGo Inc. can provide healthcare services at a lower cost compared to traditional brick-and-mortar facilities.
  • Focus on Patient Convenience: DocGo Inc.'s model prioritizes patient convenience by bringing healthcare services directly to individuals, improving access and adherence to treatment plans.

These factors collectively support DocGo Inc.'s growth trajectory, making it a noteworthy player in the evolving landscape of mobile health services. Keep exploring DocGo Inc. (DCGO): Dive deeper into DocGo Inc.'s investor profile Exploring DocGo Inc. (DCGO) Investor Profile: Who’s Buying and Why?

DCF model

DocGo Inc. (DCGO) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.